Roche diagnostic department made sales of over 27billion AUD in 2021. Currently doing some research to find their cost and breakdown of revenue of their equivalent CA15.3 test. Well probably shouldn't say equivalent because Inoviq's SubB2M enhanced CA15.3 breast cancer test is clearly superior.
Ann: Positive results for SubB2M Breast Cancer Test, page-19
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $7.597K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21334 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |